Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
The Cervarix market report offers a comprehensive analysis of market size, growth potential, and segmentation, highlighting trends across major regions. Key drivers include rising HPV awareness, vacci
Britain's GSK Asserts It Is 'Well Positioned' To Mitigate Potential Tariffs After Strong Q1 Cancer And HIV Drug Sales
09:27am, Wednesday, 30'th Apr 2025
On Wednesday, British multinational pharmaceutical GSK Plc GSK reported first-quarter sales of $9.46 billion (7.52 billion Sterling Pounds), up 2% year-over-year and 4% on constant currency. Analysts�
GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs
09:12am, Wednesday, 30'th Apr 2025
GSK stock jumped early Wednesday after the drugmaker reported adjusted earnings of $1.20 per share on $10.06 billion in first-quarter sales.
GSK Posts Strong Results, Says 'Well Positioned' in Case of Pharma Tariffs
09:06am, Wednesday, 30'th Apr 2025
U.S.-listed shares of GSK (GSK) are gaining in premarket trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the
GSK: Disproportionately discounted, but earnings beat shows signs of reappraisal
08:46am, Wednesday, 30'th Apr 2025
Shore Capital is sticking with its upbeat view on GSK PLC (LSE:GSK, NYSE:GSK), calling the stock “disproportionately discounted” after first-quarter numbers surpassed expectations and guidance was
GSK (GSK) Q1 Earnings Surpass Estimates
08:06am, Wednesday, 30'th Apr 2025
GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago.
GSK jumps 4% as earnings beat boosts confidence
07:03am, Wednesday, 30'th Apr 2025
GSK PLC (LSE:GSK, NYSE:GSK) shares rose 4% on Tuesday, adding £2.6 billion to its market value, after the drugmaker delivered better-than-expected first-quarter results and reiterated full-year guid
GSK beats earnings forecasts despite weaker vaccine sales
03:03am, Wednesday, 30'th Apr 2025
GSK PLC (LSE:GSK, NYSE:GSK) reported earnings ahead of expectations and kept full-year guidance intact, even though sales of vaccines softened. The FTSE 10-listed drugmaker reported a 6.1% fall in va
GSK Sales, Profit Rise on Boost from Cancer Drugs
02:27am, Wednesday, 30'th Apr 2025
The British pharmaceutical giant said that its first-quarter sales rose to 7.52 billion pounds from 7.36 billion pounds the year prior.
British drugmaker GSK says 'well positioned' to absorb tariff hit
02:10am, Wednesday, 30'th Apr 2025
British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact from sector-specific tariffs if they were implemented and it had identified options within
Pharma firms maastraz
12:06pm, Tuesday, 29'th Apr 2025
Jimmy Muchechetere, senior equity analyst at Investec, weighs in on the prospect of pharmaceutical tariffs and recent U.S. investment commitments from the sector.
GSK to Report First-Quarter Earnings: Is a Beat in Store?
10:15am, Monday, 28'th Apr 2025
We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Nucala, Ojjaara, Jemperli and Trelegy Ellipta to have driven first-quarter sales performance.
GSK update brings US vaccine exposure into spotlight, as sceptic RFK Jr looms
06:16am, Friday, 25'th Apr 2025
First-quarter results from GSK PLC (LSE:GSK, NYSE:GSK) will focus on commentary around the outlook, including interpretation of US policy changes under vaccine sceptic health secretary Robert Kennedy
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
11:07am, Wednesday, 23'rd Apr 2025
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
